Department of Sport Medicine and Functional Explorations, University-Hospital (CHU), Hôpital G. Montpied, Clermont-Ferrand, France.
Phys Sportsmed. 2010 Oct;38(3):121-7. doi: 10.3810/psm.2010.10.1817.
Systemic administration of glucocorticoids (GCs) is banned by the World Anti-Doping Agency (WADA) during competition. Few studies have examined the effects of GCs on exercise performance, but increasing evidence has shown that short-term GC intake enhances performance in animals and humans. However, there are many health risks associated with GC use. Based on the available evidence, as presented in this article, I conclude that GCs are doping agents and should remain on the WADA's list of banned products. Because of the complexity of GCs, however, determining the boundaries between their medical use and abuse (eg, in sports) is a constant challenge for the WADA.
世界反兴奋剂机构（WADA）禁止运动员在比赛期间进行全身糖皮质激素（GCs）治疗。虽然有一些研究探讨了 GCs 对运动表现的影响，但越来越多的证据表明，短期 GCs 摄入可以提高动物和人类的运动表现。然而，GCs 的使用也存在许多健康风险。基于本文中呈现的现有证据，我认为 GCs 是兴奋剂，应该继续被列入 WADA 的禁药名单。然而，由于 GCs 的复杂性，确定其在医学用途和滥用（例如，在运动中）之间的界限，对 WADA 来说是一个持续的挑战。
